Skip to main content
. 2022 Jan 28;11(1):36. doi: 10.1167/tvst.11.1.36

Table 1.

Patient Demographic, Clinical, and Genetic Data

BCVA (logMar)
ID Gender Age (y) Race/Ethnicity OD OS Group ABCA4 Variants
1 F 22 White 0.7 0.8 3 c.2915C>A p.(Thr972Asn); c.6079C>T p.(Leu2027Phe)
2 F 18 White 0.8 0.8 2 c.3322C>T p.(Arg1108Cys); c.4234C>T p.(Gln1412*)
3 F 58 White 0.6 0.6 3 c.5603A>T p.(Asn1868Ile); c.6229C>T p.(Arg2077Trp)
4 M 26 White 0.5 0.5 2 c.161G>A p.(Cys54Tyr); c.5196+1137G>A p.[=,Met1733Glufs*78]
5 M 18 White 1.3 1.3 3 c.[1622T>C;3113C>T] p.([Leu541Pro;Ala1038Val]); c.5603A>T p.(Asn1868Ile)
6 F 30 White/Indian 0.7 0.6 1 c.634C>T p.(Arg212Cys); c.5882G>A p.(Gly1961Glu)
7 F 31 African American 0.9 0.9 2 c.2971G>C p.(Gly991Arg); c.3413T>C p.(Leu1138Pro)
8 F 17 White 0.9 0.7 2 c.4139C>T p.(Pro1380Leu); c.5714+5G>A p.[=,Glu1863Leufs*33]
9 M 30 White 0.3 0.3 2 c.3007C>T p.(Gln1003*); c.[3758C>T;5882G>A] p.([Thr1253Met;Gly1961Glu])
10 M 13 White 1.3 1.3 3 c.[1622T>C;3113C>T] p.([Leu541Pro;Ala1038Val]); c.5603A>T p.(Asn1868Ile)
11 M 14 White 0.4 0.9 3 c.2918+5G>A p.(?); c.2966T>C p.(Val989Ala)
12 M 16 White 0.7 0.9 2 c.3292C>T p.(Arg1098Cys); c.[5461-10T>C;5603A>T] p.(Thr1821Aspfs*6)
13 F 39 White 0.3 0.8 3 c.5351T>G p.(Leu1784Arg); c.6449G>A p.(Cys2150Tyr)
14 M 17 White 0.4 0.6 1 c.1844T>C p.(Val615Ala); c.5882G>A p.(Gly1961Glu)
15 F 23 White 0.7 0.6 1 c.5044_5058delGTTGCCATCTGCGTG p.(Val1682_Val1686del); c.5882G>A p.(Gly1961Glu)
16 M 33 White 0.2 0.3 2 c.4947delC p.(Glu1650fs*12); c.5882G>A p.(Gly1961Glu)
17 M 18 White 0.7 0.7 2 c.[2588G>C;5603A>T] p.([Gly863Ala, Gly863del;Asn1868Ile]); c.5316G>A p.(Trp1772*)
18 M 13 White 0.8 0.8 2 c.[1622T>C;3113C>T] p.([Leu541Pro;Ala1038Val]); c.6079C>T p.(Leu2027Phe)
19 M 18 White 0.3 0.4 3 c.[1622T>C;3113C>T] p.([Leu541Pro;Ala1038Val]); c.6079C>T p.(Leu2027Phe)
20 M 33 Indian 0.6 0.5 1 c.1957C>T p.(Arg653Cys); c.5882G>A p.(Gly1961Glu)
21 M 38 Indian 0.6 0.8 2 c.859-9T>C p.([=,Phe287_Arg452del]); c.859-9T>C p.([=,Phe287_Arg452del])
22 M 52 White 0.2 0.2 3 c.1522C>T p.(Arg508Cys); c.4224G>A p.(Trp1408*)
23 F 37 White 0.9 0.9 3 c.4139C>T p.(Pro1380Leu); c.5882G>A p.(Gly1961Glu)
24* M 33 White 0.5 0.3 3 c.[3758C>T;5882G>A] p.([Thr1253Met;Gly1961Glu]); nd
25 M 28 White 0.6 0.6 3 c.4139C>T p.(Pro1380Leu); c.5882G>A p.(Gly1961Glu)
26 M 28 White 0.9 0.9 2 c.[5461-10T>C;5603A>T] p.(Thr1821Aspfs*6); c.5882G>A p.(Gly1961Glu)

BCVA, best corrected visual acuity.

*

One disease-causing allele identified.